Day 1 - 22 April 2013
| 8:00-9:15 | Registration | ||
| 9:15-9:30 |  OpeningAvi Treves Sheba Cancer Research Center, Chairman, Israstem 2013, Israel  |
||
| 09:30 - 10:10 Plenary Session: Chair: Avi Treves |
 Repurposing Cord Blood for Transplantation and Regenerative Medicine Joanne Kurtzberg Duke University Medical Center NC, USA  |
||
| 10:10 - 10:40 | Coffee break | ||
| Hall A - Rayman Central | Hall B - Rayman West | ||
| 10:40-12:40 |
 Clinical Studies in Progress Chair: Joseph Itskovitz-Eldor Technion - Israel Institute of Technology, Rambam Health Care Campus, Accellta Ltd., Haifa, Israel |
 Session B:Tools for Research and Development Chair: Eytan Abraham Product Innovation Research Manager Pluristem, Israel |
|
| 10:40 - 11:00 Keynote Lecture: |
Transplantation of Mesenchymal Stromal Cells Secreting Neurotrophic Factors Shows Safety and Initial Indications of Clinical Benefit in ALS Patients in a Phase I/II Clinical Trial Daniel Offen BrainStorm Cell Therapeutics Ltd., Petach-Tikva, Israel |
Development of a Scale Up Process for Undifferentiated Human Pluripotent Stem Cells in an Industrial Bioreactor Michal Amit Stem Cells Center, Technion Faculty of Medicine, Haifa, Israel |
|
| 11:00 - 11:20 | Bringing Your Stem Cell Product to Market Faster D. A. Prasanna GM Ecron Acunova CRO, Bangalore, India  |
Cytokines and Growth Factors Used as Raw Materials for Cell and Tissue Based Products Bernd Leistler Development & Production, CellGenix GmbH, Freiburg, Germany  |
|
| 11:20 - 11:40 | Intramyocardial Delivered Mesenchymal Stromal Cells Therapy in Patients with Chronic Refractory Angina – 3 Years Follow-up Jens Kastrup Cardiology Stem Cell Center, Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark  |
Toward a Serum-Free, Xeno-Free Culture System for Optimal Growth and Expansion of hMSC Suited to Therapeutic Applications Mira Genser-Nir Biological Industries, Kibbutz Beit Haemek, Israel |
|
| 11:40 - 12:00 | A Prospective Multi-Center 24 Week Observational Study Evaluating Wound Healing Outcomes in 131 Patients Treated with Human Activated Leukocytes Suspension, an Advanced Cell Therapy Adi Zuloff-Shani Macrocure, Ramat-Gan, Israel |
A Novel Method for Subretinal Transplantation of Human Adult Bone Marrow Mesenchymal Stem Cells Ameliorates the Deterioration of Retinal Structure and Function in a Rat Model of Retinal Dystrophies Ygal Rotenstreich Goldschleger Eye Research Institute, Tel Aviv University, Sheba Medical Center, Tel Hashomer, Israel |
|
| 12:00 - 12:20 | Adoptive Transfer of Tumor Infiltrating Lymphocytes in Metastatic Melanoma Patients: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies Michal J Besser Ella Institute for Melanoma, Sheba Medical Center, Ramat Gan, Israel |
Cell Therapy Compliant Culture Systems for Stem Cells Mohan Vemuri R&D, Primary & Stem Cell Division, Life Technologies, Frederick, MD, USA |
|
| 12:20-12:40 | Single-Infusion of Donor Early Apoptotic Cells (Apocell) as Prophylaxis for Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation. A Phase I-IIa Clinical Trial Dror Mevorach Enlivex, Jerusalem, Israel |
An Innovative Manufacturing Strategy to Expand MSCs Using a Closed and Automated Device – A Case Study Stefano Baila Terumo BCT, Zaventem, Belgium  |
|
| 12:30 - 14:00 | Lunch break | ||
| 14:00 - 14:40 Plenary Session: Chair: Shosh Merchav |
|
||
| 14:40 - 15:10 | Coffee break | ||
| Hall A - Rayman Central | Hall B - Rayman West | ||
| 15:10-16:50 |  Session C:New Technologies in Translation Chair: Benjamin Dekel Pediatric Stem Cell Research Institute, Sheba Medical Center & KidneyCure, Israel |
|
|
| 15:10 - 15:30 Keynote Lecture: |
Human Pluripotent Stem Cells: Implications for Basic and Translational Cardiac Research Lior Gepstein Medicine, Technion, Haifa, Israel |
The Gamida Cell Chronicles: Diary of a Clinical Adventure Einat Galamidi Cohen Gamida Cell, Jerusalem, Israel |
|
| 15:30 - 15:50 | Biomaterials for Translational Regenerative Medicine Smadar Cohen Biotechnology Engineering, Ben-Gurion University, Beer Sheva, Israel |
A Novel Technology for Replenishment of Articular Lesions Gila Maor Anatomy and Сell Biology, Technion / Carticure Ltd., Haifa, Israel |
|
| 15:50 - 16:10 | Engineering Stem Cell Microenvironments for Controlled Induction of Differentiation Shulamit Levenberg Biomedical Engineering, Technion, Haifa, Israel |
Cellection of Stem Cells - Moving from Membrane to Function Shai Yarkoni Cellect Biotechnology Ltd., Kfar-Saba, Israel |
|
| 16:10 - 16:30 | Committed Embryonic Tissue as a Novel Source for Tissue Regeneration Yair Reisner Immunology, Weizmann Institute of Science, Rehovot, Israel |
Kadimastem: Stem Cells to Cure Diseases Arik Hasson Research & Development, Kadimastem Ltd, Ness Ziona, Israel |
|
| 16:30 – 16:50 | Implementation of Advanced Autologous Cell-Based Therapy for Diabetic Patients Sarah Ferber Orgenesis, Haifa, Israel |
Human Embryonic Stem Cells in The Fight to Save Sight Charles Irving Cell Cure Neurosciences Ltd., Jerusalem, Israel |
|
Session D:This program is subject to change
